{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T04:39:03Z","timestamp":1774413543686,"version":"3.50.1"},"reference-count":84,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2019,2,21]],"date-time":"2019-02-21T00:00:00Z","timestamp":1550707200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001871","name":"Funda??o para a Ci?ncia e a Tecnologia","doi-asserted-by":"publisher","award":["SFRH\/BPD\/116784\/2016"],"award-info":[{"award-number":["SFRH\/BPD\/116784\/2016"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"Funda??o para a Ci?ncia e a Tecnologia","doi-asserted-by":"publisher","award":["POCI-01-0145-FEDER-007038"],"award-info":[{"award-number":["POCI-01-0145-FEDER-007038"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Programa Operacional Regional do Norte de Portugal","award":["NORTE-01-0145-FEDER- 000013"],"award-info":[{"award-number":["NORTE-01-0145-FEDER- 000013"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Oncol."],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1007\/s13402-019-00426-2","type":"journal-article","created":{"date-parts":[[2019,2,21]],"date-time":"2019-02-21T12:18:09Z","timestamp":1550751489000},"page":"303-318","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":43,"title":["Clinical significance of metabolism-related biomarkers in non-Hodgkin lymphoma \u2013 MCT1 as potential target in diffuse large B cell lymphoma"],"prefix":"10.1007","volume":"42","author":[{"given":"Julieta","family":"Afonso","sequence":"first","affiliation":[]},{"given":"Tatiana","family":"Pinto","sequence":"additional","affiliation":[]},{"given":"Susana","family":"Sim\u00f5es-Sousa","sequence":"additional","affiliation":[]},{"given":"Fernando","family":"Schmitt","sequence":"additional","affiliation":[]},{"given":"Adhemar","family":"Longatto-Filho","sequence":"additional","affiliation":[]},{"given":"C\u00e9line","family":"Pinheiro","sequence":"additional","affiliation":[]},{"given":"Herlander","family":"Marques","sequence":"additional","affiliation":[]},{"given":"F\u00e1tima","family":"Baltazar","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2019,2,21]]},"reference":[{"key":"426_CR1","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1016\/S0140-6736(16)32407-2","volume":"390","author":"JO Armitage","year":"2017","unstructured":"J.O. Armitage, R.D. Gascoyne, M.A. Lunning, F. Cavalli, Non-Hodgkin lymphoma. Lancet 390, 298\u2013310 (2017). \n                    https:\/\/doi.org\/10.1016\/S0140-6736(16)32407-2","journal-title":"Lancet"},{"key":"426_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/978-3-319-13150-4_1","volume":"165","author":"BC Chiu","year":"2015","unstructured":"B.C. Chiu, N. Hou, Epidemiology and etiology of non-hodgkin lymphoma. Cancer Treat Res 165, 1\u201325 (2015). \n                    https:\/\/doi.org\/10.1007\/978-3-319-13150-4_1","journal-title":"Cancer Treat Res"},{"key":"426_CR3","doi-asserted-by":"publisher","first-page":"E359","DOI":"10.1002\/ijc.29210","volume":"136","author":"J Ferlay","year":"2015","unstructured":"J. Ferlay, I. Soerjomataram, R. Dikshit, S. Eser, C. Mathers, M. Rebelo, D.M. Parkin, D. Forman, F. Bray, Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 136, E359\u2013E386 (2015). \n                    https:\/\/doi.org\/10.1002\/ijc.29210","journal-title":"Int J Cancer"},{"key":"426_CR4","doi-asserted-by":"publisher","first-page":"2375","DOI":"10.1182\/blood-2016-01-643569","volume":"127","author":"SH Swerdlow","year":"2016","unstructured":"S.H. Swerdlow, E. Campo, S.A. Pileri, N.L. Harris, H. Stein, R. Siebert, R. Advani, M. Ghielmini, G.A. Salles, A.D. Zelenetz, E.S. Jaffe, The 2016 revision of the World Health Organization classification of lymphoid neoplasms. Blood 127, 2375\u20132390 (2016). \n                    https:\/\/doi.org\/10.1182\/blood-2016-01-643569","journal-title":"Blood"},{"key":"426_CR5","doi-asserted-by":"publisher","first-page":"368","DOI":"10.3322\/canjclin.55.6.368","volume":"55","author":"JO Armitage","year":"2005","unstructured":"J.O. Armitage, Staging non-Hodgkin lymphoma. CA Cancer J Clin 55, 368\u2013376 (2005)","journal-title":"CA Cancer J Clin"},{"key":"426_CR6","doi-asserted-by":"publisher","unstructured":"B.D. Cheson, R.I. Fisher, S.F. Barrington, F. Cavalli, L.H. Schwartz, E. Zucca, T.A. Lister, Alliance, Australasian Leukaemia and Lymphoma Group, Eastern Cooperative Oncology Group, European Mantle Cell Lymphoma Consortium, Italian Lymphoma Foundation, European Organisation for Research, Treatment of Cancer\/Dutch Hemato-Oncology Group, Grupo Espa\u00f1ol de M\u00e9dula \u00d3sea, German High-Grade Lymphoma Study Group, German Hodgkin\u2019s Study Group, Japanese Lymphoma Study Group, Lymphoma Study Association, NCIC Clinical Trials Group, Nordic Lymphoma Study Group, Southwest Oncology Group, United Kingdom National Cancer Research Institute, Recommendations for initial evaluation, staging, and response assessment of Hodgkin and non-Hodgkin lymphoma: The Lugano classification. J Clin Oncol 32, 3059\u20133068 (2014). \n                    https:\/\/doi.org\/10.1200\/JCO.2013.54.8800","DOI":"10.1200\/JCO.2013.54.8800"},{"key":"426_CR7","doi-asserted-by":"publisher","first-page":"1821","DOI":"10.3390\/cancers6041821","volume":"6","author":"A Gallamini","year":"2014","unstructured":"A. Gallamini, C. Zwarthoed, A. Borra, Positron emission tomography (PET) in oncology. Cancers 6, 1821\u20131889 (2014). \n                    https:\/\/doi.org\/10.3390\/cancers6041821","journal-title":"Cancers"},{"key":"426_CR8","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/s40644-016-0091-3","volume":"16","author":"MS Hofman","year":"2016","unstructured":"M.S. Hofman, R.J. Hicks, How we read oncologic FDG PET\/CT. Cancer Imaging 16, 35 (2016). \n                    https:\/\/doi.org\/10.1186\/s40644-016-0091-3","journal-title":"Cancer Imaging"},{"key":"426_CR9","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1007\/978-3-319-13150-4_5","volume":"165","author":"TC El-Galaly","year":"2015","unstructured":"T.C. El-Galaly, M. Hutchings, Imaging of non-hodgkin lymphomas: Diagnosis and response-adapted strategies. Cancer Treat Res 165, 125\u2013146 (2015). \n                    https:\/\/doi.org\/10.1007\/978-3-319-13150-4_5","journal-title":"Cancer Treat Res"},{"key":"426_CR10","doi-asserted-by":"publisher","first-page":"1717","DOI":"10.1182\/blood-2014-09-551556","volume":"125","author":"P Johnson","year":"2015","unstructured":"P. Johnson, H. McKenzie, How I treat advanced classical Hodgkin lymphoma. Blood 125, 1717\u20131723 (2015). \n                    https:\/\/doi.org\/10.1182\/blood-2014-09-551556","journal-title":"Blood"},{"key":"426_CR11","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1016\/j.cpet.2016.05.001","volume":"11","author":"I Platzek","year":"2016","unstructured":"I. Platzek, (18)F-Fluorodeoxyglucose PET\/MR imaging in lymphoma. PET Clin 11, 363\u2013373 (2016). \n                    https:\/\/doi.org\/10.1016\/j.cpet.2016.05.001","journal-title":"PET Clin"},{"key":"426_CR12","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.cpet.2016.08.005","volume":"12","author":"CL Wright","year":"2017","unstructured":"C.L. Wright, J.J. Maly, J. Zhang, M.V. Knopp, Advancing precision nuclear medicine and molecular imaging for lymphoma. PET Clin 12, 63\u201382 (2017). \n                    https:\/\/doi.org\/10.1016\/j.cpet.2016.08.005","journal-title":"PET Clin"},{"key":"426_CR13","doi-asserted-by":"publisher","first-page":"79","DOI":"10.3960\/jslrt.56.79","volume":"56","author":"K Miyazaki","year":"2016","unstructured":"K. Miyazaki, Treatment of diffuse large B-cell lymphoma. J Clin Exp Hematop 56, 79\u201388 (2016). \n                    https:\/\/doi.org\/10.3960\/jslrt.56.79","journal-title":"J Clin Exp Hematop"},{"key":"426_CR14","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","volume":"144","author":"D Hanahan","year":"2011","unstructured":"D. Hanahan, R.A. Weinberg, Hallmarks of cancer: The next generation. Cell 144, 646\u2013674 (2011). \n                    https:\/\/doi.org\/10.1016\/j.cell.2011.02.013","journal-title":"Cell"},{"key":"426_CR15","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1038\/nrclinonc.2017.1","volume":"14","author":"UE Martinez-Outschoorn","year":"2017","unstructured":"U.E. Martinez-Outschoorn, M. Peiris-Pages, R.G. Pestell, F. Sotgia, M.P. Lisanti, Cancer metabolism: A therapeutic perspective. Nat Rev Clin Oncol 14, 113 (2017). \n                    https:\/\/doi.org\/10.1038\/nrclinonc.2017.1","journal-title":"Nat Rev Clin Oncol"},{"key":"426_CR16","doi-asserted-by":"publisher","first-page":"3685","DOI":"10.1172\/JCI69741","volume":"123","author":"JR Doherty","year":"2013","unstructured":"J.R. Doherty, J.L. Cleveland, Targeting lactate metabolism for cancer therapeutics. J Clin Invest 123, 3685\u20133692 (2013). \n                    https:\/\/doi.org\/10.1172\/JCI69741","journal-title":"J Clin Invest"},{"key":"426_CR17","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.semcancer.2014.01.005","volume":"25","author":"UE Martinez-Outschoorn","year":"2014","unstructured":"U.E. Martinez-Outschoorn, M.P. Lisanti, F. Sotgia, Catabolic cancer-associated fibroblasts transfer energy and biomass to anabolic cancer cells, fueling tumor growth. Semin Cancer Biol 25, 47\u201360 (2014). \n                    https:\/\/doi.org\/10.1016\/j.semcancer.2014.01.005","journal-title":"Semin Cancer Biol"},{"key":"426_CR18","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1007\/s13402-018-0383-7","volume":"41","author":"G Niekerk van","year":"2018","unstructured":"G. van Niekerk, A.M. Engelbrecht, Role of PKM2 in directing the metabolic fate of glucose in cancer: A potential therapeutic target. Cell Oncol\u00a041, 343\u2013351 (2018). \n                    https:\/\/doi.org\/10.1007\/s13402-018-0383-7","journal-title":"Cell Oncol"},{"key":"426_CR19","doi-asserted-by":"publisher","first-page":"7381","DOI":"10.1128\/MCB.00440-07","volume":"27","author":"JW Kim","year":"2007","unstructured":"J.W. Kim, P. Gao, Y.C. Liu, G.L. Semenza, C.V. Dang, Hypoxia-inducible factor 1 and dysregulated c-Myc cooperatively induce vascular endothelial growth factor and metabolic switches hexokinase 2 and pyruvate dehydrogenase kinase 1. Mol Cell Biol 27, 7381\u20137393 (2007). \n                    https:\/\/doi.org\/10.1128\/MCB.00440-07","journal-title":"Mol Cell Biol"},{"key":"426_CR20","doi-asserted-by":"publisher","first-page":"2037","DOI":"10.1073\/pnas.0914433107","volume":"107","author":"A Le","year":"2010","unstructured":"A. Le, C.R. Cooper, A.M. Gouw, R. Dinavahi, A. Maitra, L.M. Deck, R.E. Royer, D.L. Vander Jagt, G.L. Semenza, C.V. Dang, Inhibition of lactate dehydrogenase a induces oxidative stress and inhibits tumor progression. Proc Natl Acad Sci U S A 107, 2037\u20132042 (2010). \n                    https:\/\/doi.org\/10.1073\/pnas.0914433107","journal-title":"Proc Natl Acad Sci U S A"},{"key":"426_CR21","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.cbi.2012.06.005","volume":"199","author":"A Kumar","year":"2012","unstructured":"A. Kumar, S. Kant, S.M. Singh, Novel molecular mechanisms of antitumor action of dichloroacetate against T cell lymphoma: Implication of altered glucose metabolism, pH homeostasis and cell survival regulation. Chem Biol Interact 199, 29\u201337 (2012). \n                    https:\/\/doi.org\/10.1016\/j.cbi.2012.06.005","journal-title":"Chem Biol Interact"},{"key":"426_CR22","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1016\/j.taap.2013.09.005","volume":"273","author":"A Kumar","year":"2013","unstructured":"A. Kumar, S. Kant, S.M. Singh, Antitumor and chemosensitizing action of dichloroacetate implicates modulation of tumor microenvironment: A role of reorganized glucose metabolism, cell survival regulation and macrophage differentiation. Toxicol Appl Pharmacol 273, 196\u2013208 (2013). \n                    https:\/\/doi.org\/10.1016\/j.taap.2013.09.005","journal-title":"Toxicol Appl Pharmacol"},{"key":"426_CR23","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.trsl.2011.08.008","volume":"159","author":"NG Schaefer","year":"2012","unstructured":"N.G. Schaefer, J.F. Geschwind, J. Engles, J.W. Buchanan, R.L. Wahl, Systemic administration of 3-bromopyruvate in treating disseminated aggressive lymphoma. Transl Res 159, 51\u201357 (2012). \n                    https:\/\/doi.org\/10.1016\/j.trsl.2011.08.008","journal-title":"Transl Res"},{"key":"426_CR24","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1158\/0008-5472.CAN-13-2034","volume":"74","author":"JR Doherty","year":"2014","unstructured":"J.R. Doherty, C. Yang, K.E. Scott, M.D. Cameron, M. Fallahi, W. Li, M.A. Hall, A.L. Amelio, J.K. Mishra, F. Li, M. Tortosa, H.M. Genau, R.J. Rounbehler, Y. Lu, C.V. Dang, K.G. Kumar, A.A. Butler, T.D. Bannister, A.T. Hooper, K. Unsal-Kacmaz, W.R. Roush, J.L. Cleveland, Blocking lactate export by inhibiting the Myc target MCT1 disables glycolysis and glutathione synthesis. Cancer Res 74, 908\u2013920 (2014). \n                    https:\/\/doi.org\/10.1158\/0008-5472.CAN-13-2034","journal-title":"Cancer Res"},{"key":"426_CR25","volume-title":"WHO classification of Tumours of Haematopoietic and lymphoid tissues","author":"SH Swerdlow","year":"2008","unstructured":"S.H. Swerdlow, E. Campo, N.L.E. Harris, et al., WHO classification of Tumours of Haematopoietic and lymphoid tissues (IARC, Lyon, 2008)"},{"key":"426_CR26","doi-asserted-by":"publisher","first-page":"1630","DOI":"10.1200\/JCO.1989.7.11.1630","volume":"7","author":"TA Lister","year":"1989","unstructured":"T.A. Lister, D. Crowther, S.B. Sutcliffe, E. Glatstein, G.P. Canellos, R.C. Young, S.A. Rosenberg, C.A. Coltman, M. Tubiana, Report of a committee convened to discuss the evaluation and staging of patients with Hodgkin's disease: Cotswolds meeting. J Clin Oncol 7, 1630\u20131636 (1989). \n                    https:\/\/doi.org\/10.1200\/JCO.1989.7.11.1630","journal-title":"J Clin Oncol"},{"key":"426_CR27","doi-asserted-by":"publisher","first-page":"1386","DOI":"10.1200\/JCO.2015.63.8387","volume":"34","author":"E Hoster","year":"2016","unstructured":"E. Hoster, A. Rosenwald, F. Berger, H.W. Bernd, S. Hartmann, C. Loddenkemper, T.F. Barth, N. Brousse, S. Pileri, G. Rymkiewicz, R. Kodet, S. Stilgenbauer, R. Forstpointner, C. Thieblemont, M. Hallek, B. Coiffier, U. Vehling-Kaiser, R. Bouabdallah, L. Kanz, M. Pfreundschuh, C. Schmidt, V. Ribrag, W. Hiddemann, M. Unterhalt, J.C. Kluin-Nelemans, O. Hermine, M.H. Dreyling, W. Klapper, Prognostic value of Ki-67 index, cytology, and growth pattern in mantle-cell lymphoma: Results from randomized trials of the European mantle cell lymphoma network. J Clin Oncol 34, 1386\u20131394 (2016). \n                    https:\/\/doi.org\/10.1200\/JCO.2015.63.8387","journal-title":"J Clin Oncol"},{"key":"426_CR28","doi-asserted-by":"publisher","unstructured":"The international non-Hodgkin's lymphoma prognostic factors project, A predictive model for aggressive non-Hodgkin's lymphoma. N Engl J Med 329, 987\u2013994 (1993). \n                    https:\/\/doi.org\/10.1056\/NEJM199309303291402","DOI":"10.1056\/NEJM199309303291402"},{"key":"426_CR29","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1007\/s11864-006-0036-3","volume":"7","author":"P Solal-Celigny","year":"2006","unstructured":"P. Solal-Celigny, Follicular lymphoma international prognostic index. Curr Treat Options in Oncol 7, 270\u2013275 (2006)","journal-title":"Curr Treat Options in Oncol"},{"key":"426_CR30","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1097\/00000421-198212000-00014","volume":"5","author":"MM Oken","year":"1982","unstructured":"M.M. Oken, R.H. Creech, D.C. Tormey, J. Horton, T.E. Davis, E.T. McFadden, P.P. Carbone, Toxicity and response criteria of the eastern cooperative oncology group. Am J Clin Oncol 5, 649\u2013655 (1982)","journal-title":"Am J Clin Oncol"},{"key":"426_CR31","doi-asserted-by":"publisher","first-page":"1244","DOI":"10.1200\/JCO.1999.17.4.1244","volume":"17","author":"BD Cheson","year":"1999","unstructured":"B.D. Cheson, S.J. Horning, B. Coiffier, M.A. Shipp, R.I. Fisher, J.M. Connors, T.A. Lister, J. Vose, A. Grillo-Lopez, A. Hagenbeek, F. Cabanillas, D. Klippensten, W. Hiddemann, R. Castellino, N.L. Harris, J.O. Armitage, W. Carter, R. Hoppe, G.P. Canellos, Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas. NCI Sponsored International Working Group. J Clin Oncol 17, 1244 (1999). \n                    https:\/\/doi.org\/10.1200\/JCO.1999.17.4.1244","journal-title":"J Clin Oncol"},{"key":"426_CR32","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1200\/JCO.2006.09.2403","volume":"25","author":"BD Cheson","year":"2007","unstructured":"B.D. Cheson, B. Pfistner, M.E. Juweid, R.D. Gascoyne, L. Specht, S.J. Horning, B. Coiffier, R.I. Fisher, A. Hagenbeek, E. Zucca, S.T. Rosen, S. Stroobants, T.A. Lister, R.T. Hoppe, M. Dreyling, K. Tobinai, J.M. Vose, J.M. Connors, M. Federico, V. Diehl, L. International Harmonization, Project on, revised response criteria for malignant lymphoma. J Clin Oncol 25, 579\u2013586 (2007). \n                    https:\/\/doi.org\/10.1200\/JCO.2006.09.2403","journal-title":"J Clin Oncol"},{"key":"426_CR33","doi-asserted-by":"publisher","DOI":"10.1155\/2010\/427694","volume":"2010","author":"C Pinheiro","year":"2010","unstructured":"C. Pinheiro, R.M. Reis, S. Ricardo, A. Longatto-Filho, F. Schmitt, F. Baltazar, Expression of monocarboxylate transporters 1, 2, and 4 in human tumours and their association with CD147 and CD44. J Biomed Biotechnol 2010, 427694 (2010). \n                    https:\/\/doi.org\/10.1155\/2010\/427694","journal-title":"J Biomed Biotechnol"},{"key":"426_CR34","doi-asserted-by":"publisher","first-page":"69219","DOI":"10.18632\/oncotarget.18215","volume":"8","author":"NJ Curtis","year":"2017","unstructured":"N.J. Curtis, L. Mooney, L. Hopcroft, F. Michopoulos, N. Whalley, H. Zhong, C. Murray, A. Logie, M. Revill, K.F. Byth, A.D. Benjamin, M.A. Firth, S. Green, P.D. Smith, S.E. Critchlow, Pre-clinical pharmacology of AZD3965, a selective inhibitor of MCT1: DLBCL, NHL and Burkitt's lymphoma anti-tumor activity. Oncotarget 8, 69219\u201369236 (2017). \n                    https:\/\/doi.org\/10.18632\/oncotarget.18215","journal-title":"Oncotarget"},{"key":"426_CR35","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.3324\/haematol.2016.163030","volume":"102","author":"RA Noble","year":"2017","unstructured":"R.A. Noble, N. Bell, H. Blair, A. Sikka, H. Thomas, N. Phillips, S. Nakjang, S. Miwa, R. Crossland, V. Rand, D. Televantou, A. Long, H.C. Keun, C.M. Bacon, S. Bomken, S.E. Critchlow, S.R. Wedge, Inhibition of monocarboxyate transporter 1 by AZD3965 as a novel therapeutic approach for diffuse large B-cell lymphoma and Burkitt lymphoma. Haematologica 102, 1247\u20131257 (2017). \n                    https:\/\/doi.org\/10.3324\/haematol.2016.163030","journal-title":"Haematologica"},{"key":"426_CR36","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.semcancer.2016.12.003","volume":"43","author":"S Granja","year":"2017","unstructured":"S. Granja, D. Tavares-Valente, O. Queiros, F. Baltazar, Value of pH regulators in the diagnosis, prognosis and treatment of cancer. Semin Cancer Biol 43, 17\u201334 (2017). \n                    https:\/\/doi.org\/10.1016\/j.semcancer.2016.12.003","journal-title":"Semin Cancer Biol"},{"key":"426_CR37","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1002\/cpt.418","volume":"100","author":"RS Jones","year":"2016","unstructured":"R.S. Jones, M.E. Morris, Monocarboxylate transporters: Therapeutic targets and prognostic factors in disease. Clin Pharmacol Ther 100, 454\u2013463 (2016). \n                    https:\/\/doi.org\/10.1002\/cpt.418","journal-title":"Clin Pharmacol Ther"},{"key":"426_CR38","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1093\/neuonc\/nos298","volume":"15","author":"V Miranda-Goncalves","year":"2013","unstructured":"V. Miranda-Goncalves, M. Honavar, C. Pinheiro, O. Martinho, M.M. Pires, C. Pinheiro, M. Cordeiro, G. Bebiano, P. Costa, I. Palmeirim, R.M. Reis, F. Baltazar, Monocarboxylate transporters (MCTs) in gliomas: Expression and exploitation as therapeutic targets. Neuro-Oncology 15, 172\u2013188 (2013). \n                    https:\/\/doi.org\/10.1093\/neuonc\/nos298","journal-title":"Neuro-Oncology"},{"key":"426_CR39","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1530\/ERC-13-0132","volume":"21","author":"F Morais-Santos","year":"2014","unstructured":"F. Morais-Santos, V. Miranda-Goncalves, S. Pinheiro, A.F. Vieira, J. Paredes, F.C. Schmitt, F. Baltazar, C. Pinheiro, Differential sensitivities to lactate transport inhibitors of breast cancer cell lines. Endocr Relat Cancer 21, 27\u201338 (2014). \n                    https:\/\/doi.org\/10.1530\/ERC-13-0132","journal-title":"Endocr Relat Cancer"},{"key":"426_CR40","doi-asserted-by":"publisher","first-page":"1574","DOI":"10.1007\/s10495-013-0894-7","volume":"18","author":"A Kumar","year":"2013","unstructured":"A. Kumar, S. Kant, S.M. Singh, Targeting monocarboxylate transporter by alpha-cyano-4-hydroxycinnamate modulates apoptosis and cisplatin resistance of Colo205 cells: Implication of altered cell survival regulation. Apoptosis 18, 1574\u20131585 (2013). \n                    https:\/\/doi.org\/10.1007\/s10495-013-0894-7","journal-title":"Apoptosis"},{"key":"426_CR41","doi-asserted-by":"publisher","first-page":"3930","DOI":"10.1172\/JCI36843","volume":"118","author":"P Sonveaux","year":"2008","unstructured":"P. Sonveaux, F. Vegran, T. Schroeder, M.C. Wergin, J. Verrax, Z.N. Rabbani, C.J. De Saedeleer, K.M. Kennedy, C. Diepart, B.F. Jordan, M.J. Kelley, B. Gallez, M.L. Wahl, O. Feron, M.W. Dewhirst, Targeting lactate-fueled respiration selectively kills hypoxic tumor cells in mice. J Clin Invest 118, 3930\u20133942 (2008). \n                    https:\/\/doi.org\/10.1172\/JCI36843","journal-title":"J Clin Invest"},{"key":"426_CR42","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1158\/1078-0432.CCR-13-2270","volume":"20","author":"R Polanski","year":"2014","unstructured":"R. Polanski, C.L. Hodgkinson, A. Fusi, D. Nonaka, L. Priest, P. Kelly, F. Trapani, P.W. Bishop, A. White, S.E. Critchlow, P.D. Smith, F. Blackhall, C. Dive, C.J. Morrow, Activity of the monocarboxylate transporter 1 inhibitor AZD3965 in small cell lung cancer. Clin Cancer Res 20, 926\u2013937 (2014). \n                    https:\/\/doi.org\/10.1158\/1078-0432.CCR-13-2270","journal-title":"Clin Cancer Res"},{"key":"426_CR43","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0136142","volume":"10","author":"M Mushtaq","year":"2015","unstructured":"M. Mushtaq, S. Darekar, G. Klein, E. Kashuba, Different mechanisms of regulation of the Warburg effect in Lymphoblastoid and Burkitt lymphoma cells. PLoS One 10, e0136142 (2015). \n                    https:\/\/doi.org\/10.1371\/journal.pone.0136142","journal-title":"PLoS One"},{"key":"426_CR44","doi-asserted-by":"publisher","first-page":"3037","DOI":"10.1038\/onc.2015.360","volume":"35","author":"L Gan","year":"2016","unstructured":"L. Gan, R. Xiu, P. Ren, M. Yue, H. Su, G. Guo, D. Xiao, J. Yu, H. Jiang, H. Liu, G. Hu, G. Qing, Metabolic targeting of oncogene MYC by selective activation of the proton-coupled monocarboxylate family of transporters. Oncogene 35, 3037\u20133048 (2016). \n                    https:\/\/doi.org\/10.1038\/onc.2015.360","journal-title":"Oncogene"},{"issue":"158","key":"426_CR45","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1186\/s12967-017-1258-9","volume":"15","author":"M Broecker-Preuss","year":"2017","unstructured":"M. Broecker-Preuss, N. Becher-Boveleth, A. Bockisch, U. Duhrsen, S. Muller, Regulation of glucose uptake in lymphoma cell lines by c-MYC- and PI3K-dependent signaling pathways and impact of glycolytic pathways on cell viability. J Transl Med 15(158), 158 (2017). \n                    https:\/\/doi.org\/10.1186\/s12967-017-1258-9","journal-title":"J Transl Med"},{"key":"426_CR46","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1186\/1479-5876-12-118","volume":"12","author":"C Pinheiro","year":"2014","unstructured":"C. Pinheiro, V. Penna, F. Morais-Santos, L.F. Abrahao-Machado, G. Ribeiro, E.C. Curcelli, M.V. Olivieri, S. Morini, I. Valenca, D. Ribeiro, F.C. Schmitt, R.M. Reis, F. Baltazar, Characterization of monocarboxylate transporters (MCTs) expression in soft tissue sarcomas: Distinct prognostic impact of MCT1 sub-cellular localization. J Transl Med 12, 118 (2014). \n                    https:\/\/doi.org\/10.1186\/1479-5876-12-118","journal-title":"J Transl Med"},{"key":"426_CR47","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1053\/j.seminoncol.2013.04.016","volume":"40","author":"UE Martinez-Outschoorn","year":"2013","unstructured":"U.E. Martinez-Outschoorn, D. Whitaker-Menezes, M. Valsecchi, M.P. Martinez-Cantarin, A. Dulau-Florea, J. Gong, A. Howell, N. Flomenberg, R.G. Pestell, J. Wagner, C. Arana-Yi, M. Sharma, F. Sotgia, M.P. Lisanti, Reverse Warburg effect in a patient with aggressive B-cell lymphoma: Is lactic acidosis a paraneoplastic syndrome? Semin Oncol 40, 403\u2013418 (2013). \n                    https:\/\/doi.org\/10.1053\/j.seminoncol.2013.04.016","journal-title":"Semin Oncol"},{"key":"426_CR48","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1053\/j.seminoncol.2017.10.002","volume":"44","author":"M Gooptu","year":"2017","unstructured":"M. Gooptu, D. Whitaker-Menezes, J. Sprandio, M. Domingo-Vidal, Z. Lin, G. Uppal, J. Gong, R. Fratamico, B. Leiby, A. Dulau-Florea, J. Caro, U. Martinez-Outschoorn, Mitochondrial and glycolytic metabolic compartmentalization in diffuse large B-cell lymphoma. Semin Oncol 44, 204\u2013217 (2017). \n                    https:\/\/doi.org\/10.1053\/j.seminoncol.2017.10.002","journal-title":"Semin Oncol"},{"key":"426_CR49","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1053\/j.seminoncol.2017.10.003","volume":"44","author":"L Mikkilineni","year":"2017","unstructured":"L. Mikkilineni, D. Whitaker-Menezes, M. Domingo-Vidal, J. Sprandio, P. Avena, P. Cotzia, A. Dulau-Florea, J. Gong, G. Uppal, T. Zhan, B. Leiby, Z. Lin, B. Pro, F. Sotgia, M.P. Lisanti, U. Martinez-Outschoorn, Hodgkin lymphoma: A complex metabolic ecosystem with glycolytic reprogramming of the tumor microenvironment. Semin Oncol 44, 218\u2013225 (2017). \n                    https:\/\/doi.org\/10.1053\/j.seminoncol.2017.10.003","journal-title":"Semin Oncol"},{"key":"426_CR50","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.critrevonc.2016.11.010","volume":"109","author":"MI Mitchell","year":"2017","unstructured":"M.I. Mitchell, A.M. Engelbrecht, Metabolic hijacking: A survival strategy cancer cells exploit? Crit Rev Oncol Hematol 109, 1\u20138 (2017). \n                    https:\/\/doi.org\/10.1016\/j.critrevonc.2016.11.010","journal-title":"Crit Rev Oncol Hematol"},{"key":"426_CR51","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1007\/s13402-018-0388-2","volume":"41","author":"P Nilendu","year":"2018","unstructured":"P. Nilendu, S.C. Sarode, D. Jahagirdar, I. Tandon, S. Patil, G.S. Sarode, J.K. Pal, N.K. Sharma, Mutual concessions and compromises between stromal cells and cancer cells: Driving tumor development and drug resistance. Cell Oncol 41, 353\u2013367 (2018). \n                    https:\/\/doi.org\/10.1007\/s13402-018-0388-2","journal-title":"Cell Oncol"},{"key":"426_CR52","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1002\/pros.22620","volume":"73","author":"N Pertega-Gomes","year":"2013","unstructured":"N. Pertega-Gomes, J.R. Vizcaino, C. Gouveia, C. Jeronimo, R.M. Henrique, C. Lopes, F. Baltazar, Monocarboxylate transporter 2 (MCT2) as putative biomarker in prostate cancer. Prostate 73, 763\u2013769 (2013). \n                    https:\/\/doi.org\/10.1002\/pros.22620","journal-title":"Prostate"},{"key":"426_CR53","doi-asserted-by":"publisher","first-page":"1410","DOI":"10.1227\/01.NEU.0000143034.62913.59","volume":"55","author":"SP Mathupala","year":"2004","unstructured":"S.P. Mathupala, P. Parajuli, A.E. Sloan, Silencing of monocarboxylate transporters via small interfering ribonucleic acid inhibits glycolysis and induces cell death in malignant glioma: An in vitro study. Neurosurgery 55, 1410\u20131419; discussion 1419 (2004)","journal-title":"Neurosurgery"},{"issue":"1\u20138","key":"426_CR54","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1080\/01902148.2017.1328714","volume":"43","author":"A Giatromanolaki","year":"2017","unstructured":"A. Giatromanolaki, E. Sivridis, S. Arelaki, M.I. Koukourakis, Expression of enzymes related to glucose metabolism in non-small cell lung cancer and prognosis. Exp Lung Res 43(1\u20138), 167\u2013174 (2017). \n                    https:\/\/doi.org\/10.1080\/01902148.2017.1328714","journal-title":"Exp Lung Res"},{"key":"426_CR55","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1002\/mc.22309","volume":"55","author":"DE Jung","year":"2016","unstructured":"D.E. Jung, J.M. Kim, C. Kim, S.Y. Song, Embigin is overexpressed in pancreatic ductal adenocarcinoma and regulates cell motility through epithelial to mesenchymal transition via the TGF-beta pathway. Mol Carcinog 55, 633\u2013645 (2016). \n                    https:\/\/doi.org\/10.1002\/mc.22309","journal-title":"Mol Carcinog"},{"key":"426_CR56","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1007\/s00428-007-0558-5","volume":"452","author":"C Pinheiro","year":"2008","unstructured":"C. Pinheiro, A. Longatto-Filho, C. Scapulatempo, L. Ferreira, S. Martins, L. Pellerin, M. Rodrigues, V.A. Alves, F. Schmitt, F. Baltazar, Increased expression of monocarboxylate transporters 1, 2, and 4 in colorectal carcinomas. Virchows Arch 452, 139\u2013146 (2008). \n                    https:\/\/doi.org\/10.1007\/s00428-007-0558-5","journal-title":"Virchows Arch"},{"key":"426_CR57","doi-asserted-by":"publisher","first-page":"44403","DOI":"10.18632\/oncotarget.5623","volume":"6","author":"C Pinheiro","year":"2015","unstructured":"C. Pinheiro, S. Granja, A. Longatto-Filho, A.M. Faria, M.C. Fragoso, S.M. Lovisolo, A.M. Lerario, M.Q. Almeida, F. Baltazar, M.C. Zerbini, Metabolic reprogramming: A new relevant pathway in adult adrenocortical tumors. Oncotarget 6, 44403\u201344421 (2015). \n                    https:\/\/doi.org\/10.18632\/oncotarget.5623","journal-title":"Oncotarget"},{"key":"426_CR58","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1111\/jcmm.12481","volume":"19","author":"I Valenca","year":"2015","unstructured":"I. Valenca, N. Pertega-Gomes, J.R. Vizcaino, R.M. Henrique, C. Lopes, F. Baltazar, D. Ribeiro, Localization of MCT2 at peroxisomes is associated with malignant transformation in prostate cancer. J Cell Mol Med 19, 723\u2013733 (2015). \n                    https:\/\/doi.org\/10.1111\/jcmm.12481","journal-title":"J Cell Mol Med"},{"key":"426_CR59","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1007\/s11864-017-0449-1","volume":"18","author":"R Karmali","year":"2017","unstructured":"R. Karmali, L.I. Gordon, Molecular subtyping in diffuse large B cell lymphoma: Closer to an approach of precision therapy. Curr Treat Options in Oncol 18, 11 (2017). \n                    https:\/\/doi.org\/10.1007\/s11864-017-0449-1","journal-title":"Curr Treat Options in Oncol"},{"key":"426_CR60","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1007\/978-3-319-13150-4_11","volume":"165","author":"B Kubuschok","year":"2015","unstructured":"B. Kubuschok, G. Held, M. Pfreundschuh, Management of diffuse large B-cell lymphoma (DLBCL). Cancer Treat Res 165, 271\u2013288 (2015). \n                    https:\/\/doi.org\/10.1007\/978-3-319-13150-4_11","journal-title":"Cancer Treat Res"},{"key":"426_CR61","doi-asserted-by":"publisher","first-page":"19177","DOI":"10.18632\/oncotarget.3910","volume":"6","author":"F Morais-Santos","year":"2015","unstructured":"F. Morais-Santos, S. Granja, V. Miranda-Goncalves, A.H. Moreira, S. Queiros, J.L. Vilaca, F.C. Schmitt, A. Longatto-Filho, J. Paredes, F. Baltazar, C. Pinheiro, Targeting lactate transport suppresses in vivo breast tumour growth. Oncotarget 6, 19177\u201319189 (2015). \n                    https:\/\/doi.org\/10.18632\/oncotarget.3910","journal-title":"Oncotarget"},{"key":"426_CR62","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.mam.2012.05.003","volume":"34","author":"AP Halestrap","year":"2013","unstructured":"A.P. Halestrap, The SLC16 gene family - structure, role and regulation in health and disease. Mol Asp Med 34, 337\u2013349 (2013). \n                    https:\/\/doi.org\/10.1016\/j.mam.2012.05.003","journal-title":"Mol Asp Med"},{"key":"426_CR63","doi-asserted-by":"publisher","DOI":"10.1038\/srep32804","volume":"6","author":"X Xin","year":"2016","unstructured":"X. Xin, X. Zeng, H. Gu, M. Li, H. Tan, Z. Jin, T. Hua, R. Shi, H. Wang, CD147\/EMMPRIN overexpression and prognosis in cancer: A systematic review and meta-analysis. Sci Rep 6, 32804 (2016). \n                    https:\/\/doi.org\/10.1038\/srep32804","journal-title":"Sci Rep"},{"key":"426_CR64","doi-asserted-by":"publisher","first-page":"24636","DOI":"10.18632\/oncotarget.4323","volume":"6","author":"I Marchiq","year":"2015","unstructured":"I. Marchiq, J. Albrengues, S. Granja, C. Gaggioli, J. Pouyssegur, M.P. Simon, Knock out of the BASIGIN\/CD147 chaperone of lactate\/H+ symporters disproves its pro-tumour action via extracellular matrix metalloproteases (MMPs) induction. Oncotarget 6, 24636\u201324648 (2015). \n                    https:\/\/doi.org\/10.18632\/oncotarget.4323","journal-title":"Oncotarget"},{"key":"426_CR65","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1158\/0008-5472.CAN-08-2491","volume":"69","author":"MG Slomiany","year":"2009","unstructured":"M.G. Slomiany, G.D. Grass, A.D. Robertson, X.Y. Yang, B.L. Maria, C. Beeson, B.P. Toole, Hyaluronan, CD44, and emmprin regulate lactate efflux and membrane localization of monocarboxylate transporters in human breast carcinoma cells. Cancer Res 69, 1293\u20131301 (2009). \n                    https:\/\/doi.org\/10.1158\/0008-5472.CAN-08-2491","journal-title":"Cancer Res"},{"key":"426_CR66","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1002\/mc.22222","volume":"54","author":"J Afonso","year":"2014","unstructured":"J. Afonso, L.L. Santos, V. Miranda-Goncalves, A. Morais, T. Amaro, A. Longatto-Filho, F. Baltazar, CD147 and MCT1-potential partners in bladder cancer aggressiveness and cisplatin resistance. Mol Carcinog 54, 1451\u20131466 (2014). \n                    https:\/\/doi.org\/10.1002\/mc.22222","journal-title":"Mol Carcinog"},{"key":"426_CR67","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0040716","volume":"7","author":"J Hao","year":"2012","unstructured":"J. Hao, M.C. Madigan, A. Khatri, C.A. Power, T.T. Hung, J. Beretov, L. Chang, W. Xiao, P.J. Cozzi, P.H. Graham, J.H. Kearsley, Y. Li, In vitro and in vivo prostate cancer metastasis and chemoresistance can be modulated by expression of either CD44 or CD147. PLoS One 7, e40716 (2012). \n                    https:\/\/doi.org\/10.1371\/journal.pone.0040716","journal-title":"PLoS One"},{"key":"426_CR68","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1007\/s12013-014-0270-4","volume":"71","author":"H Gao","year":"2015","unstructured":"H. Gao, Q. Jiang, Y. Han, J. Peng, C. Wang, shRNA-mediated EMMPRIN silencing inhibits human leukemic monocyte lymphoma U937 cell proliferation and increases chemosensitivity to adriamycin. Cell Biochem Biophys 71, 827\u2013835 (2015). \n                    https:\/\/doi.org\/10.1007\/s12013-014-0270-4","journal-title":"Cell Biochem Biophys"},{"key":"426_CR69","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1038\/labinvest.2017.54","volume":"97","author":"J Schmidt","year":"2017","unstructured":"J. Schmidt, I. Bonzheim, J. Steinhilber, I.A. Montes-Mojarro, C. Ortiz-Hidalgo, W. Klapper, F. Fend, L. Quintanilla-Martinez, EMMPRIN (CD147) is induced by C\/EBPbeta and is differentially expressed in ALK+ and ALK- anaplastic large-cell lymphoma. Lab Invest\u00a097, 1095\u20131102 (2017). \n                    https:\/\/doi.org\/10.1038\/labinvest.2017.54","journal-title":"Lab Invest"},{"key":"426_CR70","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1007\/s12185-012-1225-4","volume":"97","author":"Y Watanabe","year":"2013","unstructured":"Y. Watanabe, H. Suefuji, Y. Hirose, H. Kaida, G. Suzuki, J. Uozumi, E. Ogo, M. Miura, K. Takasu, K. Miyazaki, K. Nakahara, M. Ishibashi, T. Okamura, K. Ohshima, N. Hayabuchi, 18F-FDG uptake in primary gastric malignant lymphoma correlates with glucose transporter 1 expression and histologic malignant potential. Int J Hematol 97, 43\u201349 (2013). \n                    https:\/\/doi.org\/10.1007\/s12185-012-1225-4","journal-title":"Int J Hematol"},{"key":"426_CR71","doi-asserted-by":"publisher","unstructured":"Y.M. Liu, X.M. Zhai, Y.W. Wu, Biological correlation between glucose transporters, Ki-67 and 2-deoxy-2-[18F]-fluoro-D-glucose uptake in diffuse large B-cell lymphoma and natural killer\/T-cell lymphoma. Genet Mol Res 15 (2016). \n                    https:\/\/doi.org\/10.4238\/gmr.15027242","DOI":"10.4238\/gmr.15027242"},{"key":"426_CR72","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.nucmedbio.2008.11.009","volume":"36","author":"HK Shim","year":"2009","unstructured":"H.K. Shim, W.W. Lee, S.Y. Park, H. Kim, Y. So, S.E. Kim, Expressions of glucose transporter types 1 and 3 and hexokinase-II in diffuse large B-cell lymphoma and other B-cell non-Hodgkin's lymphomas. Nucl Med Biol 36, 191\u2013197 (2009). \n                    https:\/\/doi.org\/10.1016\/j.nucmedbio.2008.11.009","journal-title":"Nucl Med Biol"},{"key":"426_CR73","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1007\/978-94-017-7215-0_8","volume":"867","author":"V Jurisic","year":"2015","unstructured":"V. Jurisic, S. Radenkovic, G. Konjevic, The actual role of LDH as tumor marker, Biochemical and Clinical Aspects. Adv Exp Med Biol 867, 115\u2013124 (2015). \n                    https:\/\/doi.org\/10.1007\/978-94-017-7215-0_8","journal-title":"Adv Exp Med Biol"},{"key":"426_CR74","doi-asserted-by":"publisher","first-page":"961","DOI":"10.3109\/0284186X.2015.1043026","volume":"54","author":"F Petrelli","year":"2015","unstructured":"F. Petrelli, M. Cabiddu, A. Coinu, K. Borgonovo, M. Ghilardi, V. Lonati, S. Barni, Prognostic role of lactate dehydrogenase in solid tumors: A systematic review and meta-analysis of 76 studies. Acta Oncol 54, 961\u2013970 (2015). \n                    https:\/\/doi.org\/10.3109\/0284186X.2015.1043026","journal-title":"Acta Oncol"},{"key":"426_CR75","doi-asserted-by":"publisher","first-page":"591","DOI":"10.3892\/ol.2016.4657","volume":"12","author":"W Hu","year":"2016","unstructured":"W. Hu, X. Wang, R. Yang, Evaluation of D-dimer and lactate dehydrogenase plasma levels in patients with relapsed acute leukemia. Oncol Lett 12, 591\u2013596 (2016). \n                    https:\/\/doi.org\/10.3892\/ol.2016.4657","journal-title":"Oncol Lett"},{"key":"426_CR76","doi-asserted-by":"publisher","first-page":"189","DOI":"10.5581\/1516-8484.20130055","volume":"35","author":"BM William","year":"2013","unstructured":"B.M. William, N.R. Bongu, M. Bast, R.G. Bociek, P.J. Bierman, J.M. Vose, J.O. Armitage, The utility of lactate dehydrogenase in the follow up of patients with diffuse large B-cell lymphoma. Rev Bras Hematol Hemoter 35, 189\u2013191 (2013). \n                    https:\/\/doi.org\/10.5581\/1516-8484.20130055","journal-title":"Rev Bras Hematol Hemoter"},{"key":"426_CR77","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0074853","volume":"8","author":"R Lu","year":"2013","unstructured":"R. Lu, M. Jiang, Z. Chen, X. Xu, H. Hu, X. Zhao, X. Gao, L. Guo, Lactate dehydrogenase 5 expression in non-Hodgkin lymphoma is associated with the induced hypoxia regulated protein and poor prognosis. PLoS One 8, e74853 (2013). \n                    https:\/\/doi.org\/10.1371\/journal.pone.0074853","journal-title":"PLoS One"},{"key":"426_CR78","doi-asserted-by":"publisher","unstructured":"S.J. van Kuijk, A. Yaromina, R. Houben, R. Niemans, P. Lambin, L.J. Dubois, Prognostic significance of carbonic anhydrase IX expression in Cancer patients: A meta-analysis. Front Oncol 6, 69 (2016). \n                    https:\/\/doi.org\/10.3389\/fonc.2016.00069","DOI":"10.3389\/fonc.2016.00069"},{"key":"426_CR79","doi-asserted-by":"publisher","first-page":"1432","DOI":"10.3109\/10428194.2014.933218","volume":"56","author":"LQ Chen","year":"2015","unstructured":"L.Q. Chen, C.M. Howison, C. Spier, A.T. Stopeck, S.W. Malm, M.D. Pagel, A.F. Baker, Assessment of carbonic anhydrase IX expression and extracellular pH in B-cell lymphoma cell line models. Leuk Lymphoma 56, 1432\u20131439 (2015). \n                    https:\/\/doi.org\/10.3109\/10428194.2014.933218","journal-title":"Leuk Lymphoma"},{"key":"426_CR80","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1080\/15384101.2015.1121329","volume":"15","author":"J Afonso","year":"2016","unstructured":"J. Afonso, L.L. Santos, A. Morais, T. Amaro, A. Longatto-Filho, F. Baltazar, Metabolic coupling in urothelial bladder cancer compartments and its correlation to tumor aggressiveness. Cell Cycle 15, 368\u2013380 (2016). \n                    https:\/\/doi.org\/10.1080\/15384101.2015.1121329","journal-title":"Cell Cycle"},{"key":"426_CR81","doi-asserted-by":"publisher","first-page":"5913","DOI":"10.1158\/0008-5472.CAN-16-2686","volume":"77","author":"M Beloueche-Babari","year":"2017","unstructured":"M. Beloueche-Babari, S. Wantuch, T. Casals Galobart, M. Koniordou, H.G. Parkes, V. Arunan, Y.L. Chung, T.R. Eykyn, P.D. Smith, M.O. Leach, MCT1 inhibitor AZD3965 increases mitochondrial metabolism, facilitating combination therapy and noninvasive magnetic resonance spectroscopy. Cancer Res 77, 5913\u20135924 (2017). \n                    https:\/\/doi.org\/10.1158\/0008-5472.CAN-16-2686","journal-title":"Cancer Res"},{"key":"426_CR82","doi-asserted-by":"publisher","first-page":"2516","DOI":"10.1200\/JCO.2017.35.15_suppl.2516","volume":"35","author":"SER Halford","year":"2017","unstructured":"S.E.R. Halford, P. Jones, S. Wedge, S. Hirschberg, S. Katugampola, G. Veal, G. Payne, C. Bacon, S. Potter, M. Griffin, M. Chenard-Poirier, G. Petrides, G. Holder, H.C. Keun, U. Banerji, E.R. Plummer, A first-in-human first-in-class (FIC) trial of the monocarboxylate transporter 1 (MCT1) inhibitor AZD3965 in patients with advanced solid tumours. J Clin Oncol 35, 2516\u20132516 (2017). \n                    https:\/\/doi.org\/10.1200\/JCO.2017.35.15_suppl.2516","journal-title":"J Clin Oncol"},{"key":"426_CR83","doi-asserted-by":"publisher","first-page":"16663","DOI":"10.1073\/pnas.1106123108","volume":"108","author":"R Floch Le","year":"2011","unstructured":"R. Le Floch, J. Chiche, I. Marchiq, T. Naiken, K. Ilc, C.M. Murray, S.E. Critchlow, D. Roux, M.P. Simon, J. Pouyssegur, CD147 subunit of lactate\/H+ symporters MCT1 and hypoxia-inducible MCT4 is critical for energetics and growth of glycolytic tumors. Proc Natl Acad Sci U S A 108, 16663\u201316668 (2011). \n                    https:\/\/doi.org\/10.1073\/pnas.1106123108","journal-title":"Proc Natl Acad Sci U S A"},{"key":"426_CR84","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1038\/nature11003","volume":"483","author":"J Barretina","year":"2012","unstructured":"J. Barretina, G. Caponigro, N. Stransky, K. Venkatesan, A.A. Margolin, S. Kim, C.J. Wilson, J. Lehar, G.V. Kryukov, D. Sonkin, A. Reddy, M. Liu, L. Murray, M.F. Berger, J.E. Monahan, P. Morais, J. Meltzer, A. Korejwa, J. Jane-Valbuena, F.A. Mapa, J. Thibault, E. Bric-Furlong, P. Raman, A. Shipway, I.H. Engels, J. Cheng, G.K. Yu, J. Yu, P. Aspesi Jr., M. de Silva, K. Jagtap, M.D. Jones, L. Wang, C. Hatton, E. Palescandolo, S. Gupta, S. Mahan, C. Sougnez, R.C. Onofrio, T. Liefeld, L. MacConaill, W. Winckler, M. Reich, N. Li, J.P. Mesirov, S.B. Gabriel, G. Getz, K. Ardlie, V. Chan, V.E. Myer, B.L. Weber, J. Porter, M. Warmuth, P. Finan, J.L. Harris, M. Meyerson, T.R. Golub, M.P. Morrissey, W.R. Sellers, R. Schlegel, L.A. Garraway, The Cancer cell line encyclopedia enables predictive modelling of anticancer drug sensitivity. Nature 483, 603\u2013607 (2012). \n                    https:\/\/doi.org\/10.1038\/nature11003","journal-title":"Nature"}],"container-title":["Cellular Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s13402-019-00426-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13402-019-00426-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13402-019-00426-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,20]],"date-time":"2020-02-20T19:14:35Z","timestamp":1582226075000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s13402-019-00426-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2,21]]},"references-count":84,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,6]]}},"alternative-id":["426"],"URL":"https:\/\/doi.org\/10.1007\/s13402-019-00426-2","relation":{},"ISSN":["2211-3428","2211-3436"],"issn-type":[{"value":"2211-3428","type":"print"},{"value":"2211-3436","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,2,21]]},"assertion":[{"value":"4 February 2019","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 February 2019","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. For this type of (retrospective) study formal consent is not required.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Research involving human participants"}}]}}